Neuphoria Therapeutics Inc. (NEUP) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Neuphoria Therapeutics In...

NASDAQ: NEUP · Real-Time Price · USD
13.01
-0.98 (-7.01%)
At close: Sep 12, 2025, 3:59 PM
12.86
-1.15%
After-hours: Sep 12, 2025, 07:32 PM EDT

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Neuphoria Therapeutics generated $15M in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
8
Market Cap
24.46M

Revenue Chart

History

Fiscal Year End Revenue % Change
Jun 30, 2024 0 n/a
Jun 30, 2023 0 -100.00%
Jun 30, 2022 6.06M +552.46%
Jun 30, 2021 928.07K +2794.62%
Jun 30, 2020 32.06K -98.80%
Jun 30, 2019 2.68M -2.86%
Jun 30, 2018 2.76M -33.25%
Jun 30, 2017 4.13M -20.79%
Jun 30, 2016 5.21M +2.56%
Jun 30, 2015 5.08M -71.79%
Jun 30, 2014 18.02M +1106.21%
Jun 30, 2013 1.49M +29.65%
Jun 30, 2012 1.15M -66.12%
Jun 30, 2011 3.4M +33.73%
Jun 30, 2010 2.54M -12.70%
Jun 30, 2009 2.91M +170.48%
Jun 30, 2008 1.08M +55.41%
Jun 30, 2007 693.21K +43.20%
Jun 30, 2006 484.09K +114.81%
Jun 30, 2005 225.36K +Infinity%
Jun 30, 2004 0 -100.00%
Jun 30, 2003 692.83K -23.64%
Jun 30, 2002 907.33K +51.47%
Jun 30, 2001 599K +Infinity%
Jun 30, 2000 0 n/a
Jun 30, 1999 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.